Levofloxacin Tablet, Film Coated
Product Images NDC 68071-3218

6 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 68071-3218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 3218 1

68071 3218 1
Levofloxacin 750 mg film-coated tablets label by NuCare Pharmaceuticals, Inc. The label indicates the package contains 10 tablets. The tablets are capsule shaped, white, and debossed with '18' on one side and 'I' on the other. The label includes the NDC 68071-3218-1 and storage instructions to keep at controlled temperature 68-77°F. Additional information includes manufacturer details and warnings.*
FDA Label Image

Levofloxacinaddress1 (Levofloxacinaddress1)

FDA Label Image

Levofloxacinaddress2 (Levofloxacinaddress2)

FDA Label Image

Levofloxacinfigure1 (Levofloxacinfigure1)

Levofloxacinfigure1 (Levofloxacinfigure1)
Chemical structure of Levofloxacin shown as a 2D molecular diagram, including atoms, bonds, and a half water molecule (½ H2O) indicated.*
FDA Label Image

Levofloxacinfigure2 (Levofloxacinfigure2)

Levofloxacinfigure2 (Levofloxacinfigure2)
A pharmacokinetic graph showing plasma concentration (mcg/mL) of Levofloxacin 750 mg over time (hours) for both oral tablet and IV infusion routes. The graph displays concentration decline from peak levels through 36 hours post-dose.*
FDA Label Image

Levofloxacinfigure3 (Levofloxacinfigure3)

Levofloxacinfigure3 (Levofloxacinfigure3)
A line graph depicting plasma concentration (mg/mL) over time (hours) for 500 mg doses of Levofloxacin administered orally (p.o.) and intravenously (i.v.). The plot shows plasma concentration decreasing over 36 hours for both administration routes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.